Selected research
Market Structure
Global IV Administration Primary Set Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global IV Administration Primary Set market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of IV Administration Primary Set include BD, SB Kawasumi, Amsino, Bayer, Baxter International, Zyno Medical, Smiths Medical, MPS Medical and Medtec Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global IV Administration Primary Set market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of IV Administration Primary Set and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents IV Administration Primary Set sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IV Administration Primary Set market size, projected growth trends, production technologies, key applications, and end-use industries.
IV Administration Primary Set Segment by Company
BD
SB Kawasumi
Amsino
Bayer
Baxter International
Zyno Medical
Smiths Medical
MPS Medical
Medtec Medical
MedSource Labs
ICU Medical
Eitan Group
CODAN US Corporation
B. Braun
Advanced Medical Systems
3M
IV Administration Primary Set Segment by Type
1 - 200 Micron
More Than 200 Micron
Less Than 1 Micron
IV Administration Primary Set Segment by Application
Hospitals
Clinics
Other
IV Administration Primary Set Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IV Administration Primary Set market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IV Administration Primary Set and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IV Administration Primary Set.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the IV Administration Primary Set market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IV Administration Primary Set manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IV Administration Primary Set in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of IV Administration Primary Set in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 1 - 200 Micron
- More Than 200 Micron
- Less Than 1 Micron
Applications
- Hospitals
- Clinics
- Other
Companies covered
- BD
- SB Kawasumi
- Amsino
- Bayer
- Baxter International
- Zyno Medical
- Smiths Medical
- MPS Medical
- Medtec Medical
- MedSource Labs
- ICU Medical
- Eitan Group
- CODAN US Corporation
- B. Braun
- Advanced Medical Systems
- 3M
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global IV Administration Primary Set Market Size, 2021 VS 2025 VS 2032
- 1.3 Global IV Administration Primary Set Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global IV Administration Primary Set Sales Estimates and Forecasts (2021-2032)
- 1.5 Global IV Administration Primary Set Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global IV Administration Primary Set Market Dynamics
- 2.1 IV Administration Primary Set Industry Trends
- 2.2 IV Administration Primary Set Industry Drivers
- 2.3 IV Administration Primary Set Industry Opportunities and Challenges
- 2.4 IV Administration Primary Set Industry Restraints
3 IV Administration Primary Set Market by Manufacturers
- 3.1 Global IV Administration Primary Set Revenue by Manufacturers (2021-2026)
- 3.2 Global IV Administration Primary Set Sales by Manufacturers (2021-2026)
- 3.3 Global IV Administration Primary Set Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global IV Administration Primary Set Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global IV Administration Primary Set Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global IV Administration Primary Set Manufacturers, Product Type & Application
- 3.7 Global IV Administration Primary Set Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global IV Administration Primary Set Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 IV Administration Primary Set Players Market Share by Revenue in 2025
- 3.8.3 2025 IV Administration Primary Set Tier 1, Tier 2, and Tier 3
4 IV Administration Primary Set Market by Type
- 4.1 IV Administration Primary Set Type Introduction
- 4.1.1 1 - 200 Micron
- 4.1.2 More Than 200 Micron
- 4.1.3 Less Than 1 Micron
- 4.2 Global IV Administration Primary Set Sales by Type
- 4.2.1 Global IV Administration Primary Set Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global IV Administration Primary Set Sales by Type (2021-2032)
- 4.2.3 Global IV Administration Primary Set Sales Market Share by Type (2021-2032)
- 4.3 Global IV Administration Primary Set Revenue by Type
- 4.3.1 Global IV Administration Primary Set Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global IV Administration Primary Set Revenue by Type (2021-2032)
- 4.3.3 Global IV Administration Primary Set Revenue Market Share by Type (2021-2032)
5 IV Administration Primary Set Market by Application
- 5.1 IV Administration Primary Set Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global IV Administration Primary Set Sales by Application
- 5.2.1 Global IV Administration Primary Set Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global IV Administration Primary Set Sales by Application (2021-2032)
- 5.2.3 Global IV Administration Primary Set Sales Market Share by Application (2021-2032)
- 5.3 Global IV Administration Primary Set Revenue by Application
- 5.3.1 Global IV Administration Primary Set Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global IV Administration Primary Set Revenue by Application (2021-2032)
- 5.3.3 Global IV Administration Primary Set Revenue Market Share by Application (2021-2032)
6 Global IV Administration Primary Set Sales by Region
- 6.1 Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global IV Administration Primary Set Sales by Region (2021-2032)
- 6.2.1 Global IV Administration Primary Set Sales by Region (2021-2026)
- 6.2.2 Global IV Administration Primary Set Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America IV Administration Primary Set Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe IV Administration Primary Set Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific IV Administration Primary Set Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa IV Administration Primary Set Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa IV Administration Primary Set Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global IV Administration Primary Set Revenue by Region
- 7.1 Global IV Administration Primary Set Revenue by Region
- 7.1.1 Global IV Administration Primary Set Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global IV Administration Primary Set Revenue by Region (2021-2026)
- 7.1.3 Global IV Administration Primary Set Revenue by Region (2027-2032)
- 7.1.4 Global IV Administration Primary Set Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America IV Administration Primary Set Revenue (2021-2032)
- 7.2.2 North America IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe IV Administration Primary Set Revenue (2021-2032)
- 7.3.2 Europe IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific IV Administration Primary Set Revenue (2021-2032)
- 7.4.2 Asia-Pacific IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa IV Administration Primary Set Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa IV Administration Primary Set Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BD
- 8.1.1 BD Company Information
- 8.1.2 BD Business Overview
- 8.1.3 BD IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BD IV Administration Primary Set Product Portfolio
- 8.1.5 BD Recent Developments
- 8.2 SB Kawasumi
- 8.2.1 SB Kawasumi Company Information
- 8.2.2 SB Kawasumi Business Overview
- 8.2.3 SB Kawasumi IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 SB Kawasumi IV Administration Primary Set Product Portfolio
- 8.2.5 SB Kawasumi Recent Developments
- 8.3 Amsino
- 8.3.1 Amsino Company Information
- 8.3.2 Amsino Business Overview
- 8.3.3 Amsino IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Amsino IV Administration Primary Set Product Portfolio
- 8.3.5 Amsino Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer IV Administration Primary Set Product Portfolio
- 8.4.5 Bayer Recent Developments
- 8.5 Baxter International
- 8.5.1 Baxter International Company Information
- 8.5.2 Baxter International Business Overview
- 8.5.3 Baxter International IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Baxter International IV Administration Primary Set Product Portfolio
- 8.5.5 Baxter International Recent Developments
- 8.6 Zyno Medical
- 8.6.1 Zyno Medical Company Information
- 8.6.2 Zyno Medical Business Overview
- 8.6.3 Zyno Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Zyno Medical IV Administration Primary Set Product Portfolio
- 8.6.5 Zyno Medical Recent Developments
- 8.7 Smiths Medical
- 8.7.1 Smiths Medical Company Information
- 8.7.2 Smiths Medical Business Overview
- 8.7.3 Smiths Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Smiths Medical IV Administration Primary Set Product Portfolio
- 8.7.5 Smiths Medical Recent Developments
- 8.8 MPS Medical
- 8.8.1 MPS Medical Company Information
- 8.8.2 MPS Medical Business Overview
- 8.8.3 MPS Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 MPS Medical IV Administration Primary Set Product Portfolio
- 8.8.5 MPS Medical Recent Developments
- 8.9 Medtec Medical
- 8.9.1 Medtec Medical Company Information
- 8.9.2 Medtec Medical Business Overview
- 8.9.3 Medtec Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Medtec Medical IV Administration Primary Set Product Portfolio
- 8.9.5 Medtec Medical Recent Developments
- 8.10 MedSource Labs
- 8.10.1 MedSource Labs Company Information
- 8.10.2 MedSource Labs Business Overview
- 8.10.3 MedSource Labs IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 MedSource Labs IV Administration Primary Set Product Portfolio
- 8.10.5 MedSource Labs Recent Developments
- 8.11 ICU Medical
- 8.11.1 ICU Medical Company Information
- 8.11.2 ICU Medical Business Overview
- 8.11.3 ICU Medical IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 ICU Medical IV Administration Primary Set Product Portfolio
- 8.11.5 ICU Medical Recent Developments
- 8.12 Eitan Group
- 8.12.1 Eitan Group Company Information
- 8.12.2 Eitan Group Business Overview
- 8.12.3 Eitan Group IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Eitan Group IV Administration Primary Set Product Portfolio
- 8.12.5 Eitan Group Recent Developments
- 8.13 CODAN US Corporation
- 8.13.1 CODAN US Corporation Company Information
- 8.13.2 CODAN US Corporation Business Overview
- 8.13.3 CODAN US Corporation IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 CODAN US Corporation IV Administration Primary Set Product Portfolio
- 8.13.5 CODAN US Corporation Recent Developments
- 8.14 B. Braun
- 8.14.1 B. Braun Company Information
- 8.14.2 B. Braun Business Overview
- 8.14.3 B. Braun IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 B. Braun IV Administration Primary Set Product Portfolio
- 8.14.5 B. Braun Recent Developments
- 8.15 Advanced Medical Systems
- 8.15.1 Advanced Medical Systems Company Information
- 8.15.2 Advanced Medical Systems Business Overview
- 8.15.3 Advanced Medical Systems IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Advanced Medical Systems IV Administration Primary Set Product Portfolio
- 8.15.5 Advanced Medical Systems Recent Developments
- 8.16 3M
- 8.16.1 3M Company Information
- 8.16.2 3M Business Overview
- 8.16.3 3M IV Administration Primary Set Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 3M IV Administration Primary Set Product Portfolio
- 8.16.5 3M Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 IV Administration Primary Set Value Chain Analysis
- 9.1.1 IV Administration Primary Set Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 IV Administration Primary Set Production Mode & Process
- 9.2 IV Administration Primary Set Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 IV Administration Primary Set Distributors
- 9.2.3 IV Administration Primary Set Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst